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Abstract
Background: The present study protocol is designed to cover the Norwegian part of the European Union Collaborative
Project—REgioNs of Europe WorkINg together for HEALTH (RENEWING HEALTH). Self-management support is an important
element of care for persons with type 2 diabetes (T2D) for achieving metabolic control and positive lifestyle changes. Telemedicine
(TM) with or without health counseling may become an important technological aid for self-management and may provide a
user-centered model of care. In spite of many earlier studies on TM, there remains a lack of consensus in research findings about
the effect of TM interventions.
Objective: The aim of RENEWING HEALTH is to validate and evaluate innovative TM tools on a large scale through a common
evaluation, making it easier for decision makers to choose the most efficient and cost-effective technological interventions. The
Norwegian pilot study evaluates whether the introduction of a mobile phone with a diabetes diary application together with health
counseling intervention produces benefits in terms of the desired outcomes, as reflected in the hemoglobin A1c level, health-related
quality of life, behavior change, and cost-effectiveness.
Methods: The present study has a mixed-method design comprising a three-armed prospective randomized controlled trial and
qualitative interviews with study data collected at three time points: baseline, after 4 months, and after 1 year. The patients’
registrations on the application are recorded continuously and are sent securely to a server.
Results: The inclusion of patients started in March 2011, and 100% of the planned sample size is included (N=151). Of all the
participants, 26/151 patients (17.2%) are lost to follow-up by now, and 11/151 patients (7.3%) are still in the trial. Results of the
study protocol will be presented in 2014.
Conclusions: The key goals of this trial are to investigate the effect of an electronic diabetes diary app with and without health
counseling, and to determine whether health counseling is important to the continued use of the application and the patients’
health competence and acceptability. Research within this area is needed because few studies have investigated the effectiveness
of apps used in long-term interventions with this degree of self-management.
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Introduction
Overview
The prevalence of type 2 diabetes (T2D) is increasing throughout
the global population [1]. A similar trend is also evident in the
Norwegian population, where 192,421 people of the total
population (5,063,709) are estimated to have diabetes, with a
prevalence of 3.8% [2]. The impact of T2D is serious for both
the individual and society with considerable economic costs
[1,3]. Although medical competence for treating diabetes is
improving and knowledge about treatment and lifestyle factors
relating to T2D is substantial, most people with this disease do
not achieve metabolic control [4,5], and can therefore experience
diabetic complications [6].
The recent Coordination Reform in Norway has reorganized
the distribution of health resources with an increased emphasis
on the development of services within municipalities [7].
According to the Norwegian guidelines for diabetes, this
organizational redirection complies with the current
recommendations for the treatment of patients with T2D [8].
Earlier research in Norway indicated a gap between the
guidelines and current clinical practice because only one of
eight patients reaches the combined goal of control of glycemia,
blood pressure, and lipids [9]. However, improvements in
primary care for patients with T2D have been observed in
Norway in recent years [10].
A systematic review has shown that diabetes self-management
education for adults with T2D is effective when delivered in a
community context [11]. Lifestyle changes such as increased
physical activity and improved dietary habits may influence
and improve metabolic control in persons with T2D [12]. To
succeed in achieving positive lifestyle changes, the patient must
be involved, and self-management support is an important
element in the care of persons with diabetes [13] as well as
persons with any chronic diseases [14]. Enhancing diabetes
self-management strategies has shown promising results for
reducing hemoglobin A1c (HbA1c) level in this group, a change
that plays an important role in both reducing the risk for
developing complications and improving the quality of life [15].
Nurse-delivered combined motivational enhancement therapy
and cognitive behavior therapy has been shown to be feasible
for adults with poorly controlled type 1 diabetes and can lead
to an improvement in HbA1c levels [16]. However, further
research is needed for optimizing health outcomes in these
settings and for learning how to design more individualized
approaches.
The psychological burden on the individual patient caused by
the disease must also be recognized. Diabetes care providers
such as nurses and physicians must deal with patients’ everyday
problems in managing diabetes, and some patients may need to
seek help from psychosocial specialists [17]. Some earlier
research have shown a high prevalence of depression in persons
with T2D and an association between depression and poor
self-management, poor metabolic control, and diabetic
complications [18-20].
When living with and managing a chronic disease at home,
telemedicine (TM) has the potential to become an important
aid for self-management and may also help ensure a
user-centered rather than a biomedically centered model of care
[21]. Modern technology combined with psychological
interventions can be useful in providing efficient management
of diabetes. The TECNOB study is an example of how to use
technology and a cognitive behavioral approach in a
multidisciplinary telecare intervention for weight loss in obese
patients with T2D in inpatient treatment (1 month) and in the
continuity of care at home (1 year) [22,23]. Interactive systems
that integrate monitoring and personalized feedback functions
should be developed [24]. The importance of clarifying the
effect of interventions that combine telemonitoring with
educational and motivational tools, and those consisting of
telemonitoring only, is also of interest [25]. Evaluations of TM
interventions for persons with diabetes have mainly focused on
the achievement of a clinical outcome in terms of glycemic
control [26,27] with a reported trend toward patients achieving
better glycemic control [28,29]. Few studies have found
improvements in participants’ quality of life [24,28-30], but
one review investigating the impact of home telehealth
interventions on the patients’ quality of life and patient
satisfaction compared with usual care [29] refers to a study with
a single-group design that indicates significant improvements
in physical functioning, bodily pain, and social functioning after
1 year of home telehealth [31]. Satisfaction with the new
technologies has also been demonstrated, and more complex
interventions with definitions of the process of care, and links
between patients and professionals, showed better outcomes
[30]. It is important to know whether users accept this type of
service and the term “acceptability” is often used to indicate
the degree to which patients are satisfied with a service and are
willing to use it [32]. It is, therefore, recommended to design
studies considering the patients’ need for technology support
[24]. Although diabetes telemonitoring has been shown as an
effective approach both for glycemic control and for
self-management, more research within this area is needed.
Systematic reviews indicate that TM systems can be used
effectively for persons with diabetes, although this conclusion
is based on weak evidence. Further research should seek to
understand how TM may improve diabetes management and
enhance educational and self-management interventions [33,34].
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It has, for example, been shown a gap between the
evidence-based recommendations and the functionality of the
application features used in study interventions for diabetes care
[33]. Despite a large number of studies on TM and systematic
reviews on the effects of TM, a systematic review of existing
reviews raises questions about the quality of the research
evidence in terms of the approaches to evaluation and the
methodologies used. The authors indicated the need for more
focus on patients’ perspectives, economic analyses, and TM
innovations as complex processes and ongoing collaborative
achievements. Formative assessments are also of interest [35].
There is a need for studies to be designed to control for possible
mediating variables [28]. It has earlier been shown how positive
clinical outcomes might be associated with mediating variables
(or process variables) such as intensified provider consultation
[36], more active management [37], or cognitive processes [38].
Aim of the Study
The present study is the Norwegian part of the European Union
(EU) Collaborative Project—REgioNs of Europe WorkINg
together for HEALTH (RENEWING HEALTH). The aim of
this study is to validate and evaluate innovative TM tools on a
large scale using a common evaluation method, thereby making
it easier for decision makers to choose the most efficient and
cost-effective technological aids [39]. The Norwegian study
evaluates whether the introduction of personalized and
technology-supported self-management with and without health
counseling intervention produces benefits in desired outcomes,
as reflected in HbA1c level, health-related quality of life,
behavior change, and cost-effectiveness.
Theoretical Framework
In the present study, we perform a self-management intervention
focusing on behavior change and the implementation of the
evidence-based approach to diabetes self-management education
and self-management support [13]. Self-management has been
described as “the nature and scope of the ways in which patients
state that they need to change to become more active participants
in maintaining their health” [14], and the World Health
Organization “white paper” has described self-management as
a set of cognitive and behavioral self-management skills such
as coping skills, goal setting, self-monitoring, environmental
modification, self-reward, and arranging social support [40].
The health counseling part of the present study is based on
principles from cognitive behavioral therapy, the “Reach Out”
problem-solving model [41,42], and motivational interviewing
(MI) [43]. The diabetes specialist nurse will use principles of
MI such as a person-to-person interview with a client-centered
style for eliciting behavior change by helping a patient explore
and resolve ambivalence. MI is a refined form of the familiar
process of guiding and is a technique that complements the
communication skills needed by nurses and other health care
workers [43]. The transtheoretical model that provides the
diabetes specialist nurse a way of grouping the patients
according to their stage of readiness to adopt new behaviors is
also used [44,45]. Patients with T2D may have a wide variety
of problem behaviors related to diet, physical activity,
medication, and smoking. The transtheoretical model focuses
on the patient’s readiness to change and on the individual’s
decision making. The model has been used earlier to identify
patients with diabetes at different stages of readiness to change
to a healthy diet [46]. It has also been used in a successful
telephonic intervention to improve diabetes control in urban
adults in which patients were grouped according to their stage
of change within different lifestyle domains [47]. The diabetes
specialist nurse has a role as supporter, helping motivate the
patients, although the real work is being undertaken by the
patients themselves [41,42]. The term “low-intensity”
(intervention) can be seen as a “lower dose” of specific treatment
technique that may represent less support from the health
personnel (the diabetes specialist nurse in our study) in duration
and frequency of contact, and is usually delivered in a
nontraditional way such as by mobile phone [41,42].
Glasgow et al [48] documented that it is necessary to include
patient-reported psychosocial and behavioral measures in
research to address the need for support in persons with diabetes.
Methods
Study Design
The study has a mixed-method design comprising a three-armed
prospective randomized controlled trial (RCT) and qualitative
interviews. The study has been registered with Clinical Trials
(NCT01315756). Mixed-method research is a purposeful
combination of quantitative and qualitative methods to enrich
the material and to obtain a broader understanding of the
findings in a study [49]. There are different ways to conduct
the investigation and different ways of positioning the involved
methods in relation to each other. In our study, the primary
outcome measure is based on the findings from the quantitative
part, and the qualitative interviews were based on grounded
theory to provide us with additional information about the
accessibility of the study and the intervention process.
The present study has a longitudinal design, and study data are
collected at three time points: Test 1, at the time of inclusion
(baseline); Test 2, after 4 months; and Test 3, at the end of the
1-year study. The patients’ registrations on the diabetes diary
app, called the Few Touch application, are recorded
continuously and are transferred securely to a server. The
participants in the two intervention groups are using the TM
application during the 1-year study (Figure 1); one of these
groups additionally receives health counseling during the first
4 months.
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Figure 1. Design of the randomized controlled trial.
Trial Population and Recruitment
Persons with T2D are eligible to participate in the study if they
are older than 18 years, were diagnosed with diabetes for more
than 3 months before the study inclusion, and have an HbA1c
level >7.0%. Patients must be cognitively able to participate,
understand, and be able to complete questionnaires in Norwegian
language, and be able to use the mobile self-management system
provided to the intervention groups. The exclusion criteria are
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any mental or physical conditions that interfere with the
protocol.
Patients treated in primary care from both the southern and
northern parts of Norway are recruited by their general
practitioners (GPs). The GPs obtain recruitment information
from the research team and are asked to recruit eligible patients
to the study. Patients are also recruited from “diabetes start
courses” held by the specialist health care service, which are
offered to those newly diagnosed with diabetes in Norway by
local public health clinics in municipalities and by
advertisement. Patients willing to participate in the study are
first given a letter with a brief summary of the study and an
invitation to obtain more in-depth information about the study
and implications. This information is given both orally and in
written form in start-up meetings arranged by the project team.
Before entering the study, all patients are required to provide
written informed consent about their participation. All patients
included must be under the care of a GP who adheres to national
guidelines for diabetes care.
Randomization
Patients who meet our inclusion criteria sign the informed
consent form, complete the self-reported questionnaire, and are
randomized into one of the three groups through
block-randomization in the start-up meeting described above.
Randomization is performed through the Center of
Randomization at the Unit for Applied Clinical Research at the
Norwegian University of Science and Technology in Trondheim,
using WebCRF (Case Report Form). Immediately after
randomization, the patients are told which group they have been
placed. Those placed in the intervention groups are given a
mobile phone with the self-management application in the same
meeting and taught how to use the phone and the application.
Those randomized to both the application and the health
counseling group is given information about this intervention
at the end of the same meeting. The reason for choosing this
procedure is to save time for those who travel a considerable
distance to participate.
Development of the Intervention
Overview
All participants receive usual care by their GP. The patients in
the control group receive only usual care. Usual care in Norway
is regulated by national guidelines, which include at least one
annual visit to a GP. Standard measurements are blood pressure,
serum concentrations of lipids and glucose, HbA1c level, and
weight and body mass index. The patient’s regular visit with a
GP includes treatment for elevated blood glucose, blood
pressure, and lipids when needed. The GP also emphasizes the
importance of lifestyle changes [8].
There are two intervention groups (I+II) in our study. In addition
to usual care, the participants in both the intervention groups
receive a mobile phone with the diabetes diary app referred to
as the Few Touch application, which is a self-help tool
comprising five elements that are accessible to the user: (1) food
habits registration system, (2) blood glucose data management
system, (3) physical activity registration system, (4) personal
goal-setting system, and (5) general information system. Blood
glucose data are transferred automatically to the mobile
phone-based diabetes diary from the blood glucose meter when
the user has performed a measurement. Activity data and food
habits are entered manually by the user. The users can also set
personal goals for physical activity and food habits, access
related tips, and look up words and concepts related to their
disease.
In addition to the mobile phone, intervention group II also
receives theory-based health counseling delivered by a diabetes
specialist nurse working at a diabetes outpatient clinic at a
university hospital, and with the possibility of support from a
dietitian. The health counseling intervention comprises five
modules (Table 1) and is delivered over 4 months immediately
following the randomization. The nurse sends standardized short
messages (using short message service, SMS) a few days before
calling to inform the patients of the planned content in the phone
conversation. The patients are also able to initiate SMS text
messaging to communicate with the diabetes specialist nurse.
Table 1. Five modules of the health counseling intervention.
Module themeModule
IntroductionModule 1 (intro)
Living with diabetesModule 2 (1st month)
Goal settingModule 3 (2nd month)
Diet and physical activityModule 4 (3rd month)
Looking back and continuing forwardModule 5 (4th month)
The Mobile Self-Management Tool
Several projects for designing various mobile self-management
systems within diabetes have been conducted at the Norwegian
Centre for Integrated Care and Telemedicine in Norway. The
T2D tool, the Few Touch application, has been developed
together with and tested on 12 patients with diabetes, as
described in a previous publication [50]. The app was both
designed and tested in close contact with persons with diabetes
over a 3-year period. Obtaining constant feedback from
participants and having the ability to change the app as needed
during the testing-period, helped in making it a user-friendly
and practical app. Initial promising results were demonstrated
for this user-involved design process involving people with
T2D [51].
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Health Counseling
The health counseling intervention given to intervention group
II is based on a problem-solving method and is delivered by the
nurse through short telephone conversations with the patients.
The diabetes specialist nurse supports the patients to (1) assess
problems, (2) identify possible solutions, (3) analyze strengths
and weaknesses, and the main advantages and disadvantages
of each solution, (4) select a solution based on the analyses in
the stage 3, (5) plan implementation, (6) implement the
solutions, and (7) review the process and outcome. This
problem-solving model is an evidence-based low-intensity
intervention with a practical and systematic approach. It was
developed for counseling and guided self-help for groups of
patients in mental health services in the United Kingdom. The
model has been described as useful for patients with diabetes
and other chronic diseases, and requires less support from the
health care provider in terms of duration and frequency of
contact [41,42].
One of the aims of the present study is to activate the patients’
motivation toward self-management. In this regard, the MI
technique includes the following approaches in the conversation
between the patient and the clinician (the diabetes specialist
nurse in our study): (1) establishing a collaborative partnership
between the patient and the clinician to find a solution, (2)
evoking from the patients what they already have in terms of
their own motivation and resources for change, and (3) honoring
the patients’ autonomy about how to live their lives. The
clinician has to resist the “righting reflex,” understand the
patients’ motivation, and listen to and empower the patients
[43].
To guide the participants in the change process, the nurse
assesses the motivational stages [44] for each patient in relation
to diabetes-relevant areas and the use of the Few Touch
application. The health counseling is based on national
guidelines [8], and the intervention as illustrated in Figure 2 is
explained in the following text.
At the first stage, patients set goals for what kind of food intake
and physical exercise they plan in the next period. Then, the
blood glucose level is measured with Bluetooth-enabled glucose
meter that transfers blood sugar level data automatically to the
mobile phone. Thereafter, patients add food intake and activity
manually on the phone application. Accordingly, patients get
response from the application on how the individually set goals
are met within the defined period.
Parallel to the registration process, the following activities are
also carried out. First, patients in the health counseling group
have contact with the diabetes specialist nurse in parallel to
using the application, where relevant health-related questions
and results are discussed. Second, patients in both the
intervention groups (I+II), have regular consultations with their
physician where they will be able to share their application data,
if they choose to do so. Finally, responsibility and control of
their data lie with the patients.
Figure 2. Pilot drawings.
JMIR Res Protoc 2013 | vol. 2 | iss. 2 | e34 | p.6http://www.researchprotocols.org/2013/2/e34/
(page number not for citation purposes)
Ribu et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Information and Training
Both intervention groups (I+II) are instructed in using the mobile
phone-based system. In the first session, they are given a
practical presentation of the diabetes diary from the project
group, which describes the different details recorded in the
diary. This is followed by a session in which the patients try
the same functionalities on their mobile phone. They are also
given a manual for the use of the mobile phone and the Few
Touch application both in a paper-based handbook and on a
USB memory stick. The telephone support service is available
on weekdays from 9:00 to 15.00 h, when support providers are
available to answer questions and help the participants with
technical aspects. The patients are also informed through the
consent form that the project team might contact them if they
are not using the phone at all, which is discovered by lack of
registrations on the central database server. Participants in
intervention group II who additionally receive the health
counseling are given additional training in how to send and
receive SMS messages securely to the diabetes specialist nurse
or dietitian.
Power Analyses
Power analyses were performed before recruitment to estimate
the sample size needed based on the HbA1c level as the primary
outcome. Given an effect size of 0.35, a significance level of
5%, a standard deviation of the outcome variable of 0.5,
statistical power of 80%, and a two-tailed significance test, the
sample size was estimated to be 34 individuals in each group.
To compensate for dropouts, the sample was set to 50+50 (two
intervention groups), and 50 in the control group. A total of 151
patients were included.
Evaluation Measures
Overview
Our evaluation is based on the Model for Assessment of
Telemedicine (MAST), which is a framework developed for
the evaluation of the TM interventions in RENEWING
HEALTH [39]. We are also using principles from the complex
intervention framework developed by the Medical Research
Council in the United Kingdom [52]. We intend to evaluate a
large number and variety of outcomes. The consolidated
standards of reporting trials (CONSORT) statements for
reporting parallel group randomized trials are followed [53,54].
The study data include responses on self-reported questionnaires,
logs from the Few Touch application, and data collected from
patient journals obtained from the GPs. To assess the
representativeness of the sample, we will use data from the
general population with and without diabetes from the
Nord-Trøndelag Health Study (HUNT 3) in Norway [55]. We
will also conduct in-depth interviews with patients and health
care providers consecutively. In addition, we will collect data
from the technical support service to get knowledge about who
are using the service, frequency of use, and what they are asking
for. Further, we collect notes from the diabetes nurse taken
during the health counseling. The measures in our study are
described in detail below.
Demographics
These are self-reported measures and include age, sex,
education, cohabitation, marital status, and working status of
the participant.
Clinical Measures
Data from the medical records include medication, dosage,
treatment period, and adjustments during the study period. Data
about height, weight, blood pressure, and waist circumference
are also obtained from medical records. Biological data include
HbA1c and lipid levels. Frequency of hypoglycemia and
comorbidities are self-reported, and late complications such as
atrial fibrillation, intermittent claudication, cerebrovascular
disease, coronary disease, and microalbuminuria are obtained
from the GPs.
Primary Outcome Measure
The primary outcome is the difference between the control group
and the intervention groups regarding change in HbA1c level
after 4 months and after 1 year. When possible, HbA1c levels
are recorded within 2 weeks before or after the expected date
of follow-up (ie, within a 1-month window) [56]. HbA1c level
has been shown to vary between 100 laboratories in the United
Kingdom and between the various HbA1c assays in use [57].
In the present study, patients are included from different GP
offices, and there may be variations in HbA1c levels recorded.
To avoid bias potentially introduced through the use of different
HbA1c assays, the DCA Vantage Analyzer from Siemens is
used when possible.
Secondary Outcome Measures
Short Form-36 for Measuring Health-Related Quality
of Life
This questionnaire contains eight conceptual domains within
physical functioning and mental health giving scores of 0-100:
(1) physical functioning, (2) role-physical, (3) bodily pain, (4)
general health, (5) vitality, (6) social functioning, (7)
role-emotional, and (8) mental health [58,59]. It is one of the
most frequently applied surveys for measuring health-related
quality of life, and its domains are relevant for people with
diabetes [60]. The Short Form-36 (SF-36) was included in
RENEWING HEALTH to allow comparisons between different
regions included in the project and to allow comparisons with
norms.
Center for Epidemiological Studies Depression Scale
for Measuring Depression
The Center for Epidemiological Studies Depression Scale is a
tool for measuring depressive symptoms, but not for diagnosing
depression [61]. It assesses the behavioral, cognitive, and
affective symptoms of depression, and measures sleep
disturbance and loss of appetite, which can be important signs
of depression and may have major impact on diabetes
management.
JMIR Res Protoc 2013 | vol. 2 | iss. 2 | e34 | p.7http://www.researchprotocols.org/2013/2/e34/
(page number not for citation purposes)
Ribu et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Behavior Change and Empowerment
Health Education Impact Questionnaire (heiQ)
The Health Education Impact Questionnaire (heiQ) contains 40
questions to measure the effectiveness of patient education and
self-management interventions for people with chronic
conditions, as well as the patients’ health competence. It is an
eight-scale questionnaire with the following domains: (1)
positive and active engagement in life, (2) health-directed
behavior, (3) skill and technique acquisition, (4) constructive
attitudes and approaches, (5) self-monitoring and insight, (6)
health service navigation, (7) social integration and support,
and (8) emotional well-being. The instrument has been proven
to be valid and reliable [62]. The instrument has recently been
translated to Norwegian, and a psychometrically testing is
ongoing.
Diabetes Empowerment Scale-Short Form
The Diabetes Empowerment Scale-Short Form (DES-SF) has
eight items related to managing the psychosocial aspects of
diabetes, and measures readiness to change and achieve goals
[63,64]. The DES-SF has been proven to be valid and reliable,
although the short form has not been through a test-retest
validation [65]. This instrument has been translated into
Norwegian for the present study.
Physical Activity
Measures of physical activity are collected by the same questions
as in the HUNT 3 study for comparison purposes with a diabetes
sample from the general population. We have also included one
question based on the transtheoretical stages of change to assess
the respondents’motivation toward physical activity and change
in activity level [66].
Nutritional Habits
Measures of nutrition are collected using the same questions as
those used by the Cancer Registry of Norway in the Norwegian
Colorectal Cancer Prevention study, which collects data about
the intake of fruit, vegetables, and fat [67]. Motivation for
changing nutritional habits is assessed using a question based
on the transtheoretical stages of change [46].
Patient Acceptability
Measurement of the Usability of the Mobile
Self-Management Tool
The usability of the mobile self-management tool FTA Touch
application will be measured by the System Usability Scale
(SUS) that comprises 10 items to provide a global view of the
patients’ subjective assessment of usability. The SUS has been
found to be a “valuable and robust tool in helping assess the
quality of a broad spectrum of user interfaces” [68]. The measure
has been used earlier in Norway [50].
Assessment of the Patients’ Perceptions
To assess the patients’ perceptions about the mobile
self-management tool Few Touch application, the patient
acceptance questionnaire, Service User Technology
Acceptability Questionnaire, used in the Whole Systems
Demonstrator program [69] is used in all pilot studies of
RENEWING HEALTH. This questionnaire contains 22 items
within the following domains: utility of the kit, effect on health
status, effects on access to care, effects on health care/social
care, privacy, suitability of the kit, and satisfaction with the kit.
Patients’ Experiences With the Intervention
We are also integrating a qualitative evaluation with in-depth
interviews of consecutive patients at the end of the study. We
are using grounded theory [70] and have developed a
semistructured interview guide to obtain patients’ experiences
and their degree of satisfaction with the intervention. Integrating
a qualitative approach into this RCT may strengthen the
description of its effects. The interviews will be conducted by
a researcher who had no earlier contact with the patients. The
interviews will continue until saturation of data is achieved.
Health Care Perspectives
Health Care perspectives will be collected through
semistructured interviews with health care professionals,
doctors, and nurses in the GP offices and the diabetes outpatient
clinics involved in this study. The focus for this evaluation will
be facilitators for and obstacles to using the system provided
or similar systems.
Cost-Effectiveness
The objective of the economic study is to analyze whether the
interventions in addition to standard care are cost effective
compared to standard care alone. The study will be conducted
from a societal perspective; all costs and consequences falling
on the health service as well as on the patient and their
employers will be included. The analysis will include data on
investments in the TM app, as well as training costs, cost of
maintenance, and technical support. Data on health resource
use (such as GP visits, hospital admissions, and contacts with
nurses), transportation costs, and costs of foregone production
are also collected. Market prices, tariffs, and average wages
(including employment costs) will be used as cost weights or
unit costs and will be presented alongside resource data. Total
costs of the treatment arms will be compared with the benefits
of improving the patients’ health. Health benefits will be
measured in quality-adjusted life years (QALYs).
Patient-specific QALYs will be computed from the SF-36 Health
Survey by employing an estimated preference-based algorithm
developed by Brazier et al [71]. QALYs will be calculated by
using under the curve analysis, with linear interpolations
between utility scores collected at baseline, 4 months, and 12
months assessments. Incremental cost per QALY will then be
calculated and incremental cost-effectiveness ratios will be
reported and presented on the cost-effectiveness plane [72].
Statistical Analysis
Baseline measurements will be presented using descriptive
statistics. The participants will be block randomized, and the
groups should therefore be equal in age and gender distribution.
The groups will be compared with regard to clinically relevant
variables to ensure they are comparable. Because of the limited
size of the groups, they may differ on some variables and, when
such variables are identified, they will be adjusted for in the
statistical analyses, for example, by treating them as possible
confounders.
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Baseline data will be compared with data from the normal
population (HUNT 3 study) to assess whether our sample is
representative of the entire population of Norwegian individuals
living with diabetes.
The differences in the main outcome between baseline and 4
months and between baseline and 1 year will be compared
between the three groups. First, the crude difference will be
analyzed using analysis of variance with post hoc tests
(differences between groups). The difference between baseline
and the following two measurements within each group will be
analyzed using a t test. When a change in a selected outcome
variable is identified, this change will be modeled using linear
regression adjusted for possible confounders.
The cost-effectiveness data will be analyzed using standard
statistical analyses depending on the distribution of the data.
Missing values will be replaced by imputation. Mean values
and 95% CI will be reported for each component of resource
use as well as for total costs and effectiveness. Sensitivity
analyses will be conducted to handle nonsampling variation.
Our study has a longitudinal design and we expect some
dropouts. Therefore, we will perform two analyses: one based
on intention to treat and another based on the participants who
actually participated actively in our study (per protocol).
Ethical Considerations
The study has been approved by the Regional Ethics Committee.
The patients will be guaranteed full confidentiality and are
required to provide informed consent to participate in the study.
The security associated with the server will ensure the safety
of the data. Only anonymous data are sent in an encrypted way
over the Internet, and the data will be stored anonymously.
There are ethical concerns about clinical trials when some of
the patients receive the intervention, while others do not.
However, all patients will receive the usual care by their GPs,
who will be aware of their patients’ participation in the study.
Results
The inclusion of patients started in March 2011, and 100% of
the planned sample size is included (N=151). Of all the
participants, 26/151 patients (17.2%) are lost to follow-up by
now, and 11/151 patients (7.3%) are still in the trial. Results of
the study protocol will be presented in 2014. The aim of this
study is to validate and evaluate innovative TM tools on a large
scale through a common evaluation, making it easier for decision
makers to choose the most efficient and cost-effective
technological interventions.
Discussion
Despite a large number of studies of TM and systematic reviews
of the effects of TM, there remains a lack of consensus in
research findings [28]. The key elements in this trial are the
effect of an intervention that combines a mobile
self-management tool with motivational support and the
comparison with an intervention comprising TM alone. It is of
interest to investigate the effect of the TM application with and
without health counseling, and it is reasonable to question
whether health counseling is important for the continued use of
tools such as those in this study and for patients’ health
competence and acceptability. One might question whether the
health counseling part of the intervention will motivate the
patients or whether the repeated phone calls from the diabetes
nurse will become more tiresome than supportive and thus
unwanted. Research on this question is needed, but to our
knowledge, no studies have investigated this thoroughly.
We have chosen to include adult patients of all ages and some
not familiar with mobile phones. Our qualitative approach will
allow us to search for possible limitations in the use among
different groups of patients. This may give us valuable
knowledge about how to encourage the use among different
groups of patients and how to assess the effects of a
low-intensity intervention on different subgroups. Our
qualitative approach might also reveal important information
in discussions with patients and health personnel about how to
integrate self-management tools in the health care system.
The patients included in the study may represent those who are
open to new technology and who are willing to participate in a
complex intervention; thus, the acceptability to using such
devices may be lower in the wider population. It will be
important to assess representativeness. In Norway, we have data
from large population-based studies that are well suited for
comparison purposes. Recruitment to RCTs is also frequently
problematic [73,74], and one concern in the present RCT is
whether patients who are eligible will be disappointed when
they are randomized to the control group and not to an
intervention group receiving the Few Touch application or the
application together with health counseling. There is reason to
question whether an RCT is suited to this type of study when
we are recruiting possibly motivated patients to participate in
a TM intervention and they may be randomized to the control
group. Different designs that are more flexible and clinically
useful have been discussed [73], and our study may contribute
to this discussion, which is of current interest.
In the present study, we have chosen HbA1c level as the primary
outcome. Many people with diabetes have poor understanding
of their HbA1c level, and only few remember their actual test
results. The level of agreement between perceived glycemic
control and actual HbA1c values is also poor [75]. This could
be a challenge in our research when the primary outcome is a
measure of which many patients may have a poor awareness
and understanding. In addition, glycemic control may not be a
goal for some patients when they volunteer for the study.
However, the patients in the intervention groups will have access
to information about their blood glucose measures through the
Few Touch application, and one of the intervention groups will
additionally receive health counseling to help them attain
self-management and diabetes control.
Evaluations of telehealth interventions for persons with diabetes
have focused mostly on the achievement of a clinical outcome
in terms of glycemic control. Nolte et al [38] performed an
in-depth analysis of outcome measures used to evaluate chronic
disease self-management programs and found that decisions
about the value and efficacy of chronic disease self-management
programs should be interpreted with care. There is an important
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difference between clinical measures (eg, HbA1c level) and
patient-reported outcomes. The former can be assessed relatively
accurately, whereas assessments of patient-reported outcomes
have considerably more measurement error and varying degrees
of bias caused by question interpretation and personal appraisal.
There is a need for further research, qualitative studies in
particular, to unravel the cognitive processes and the role of
response shift bias in the measurement of change [76]. We will
take into account this challenge in our study by using several
evaluation-based measures requiring a large amount of personal
judgment. Our mixed-method design and inclusion of in-depth
qualitative interviews of consecutive patients leaving the study
will help us identify their experiences and reflections, and will
provide a more comprehensive description of the effects of
processes in our evaluation of the intervention.
Another concern in a complex intervention such as ours is the
benefit of the attention that all the participants receive during
the study period from different persons, for example, the effect
from the patients’ awareness that they are participants under
study (Hawthorne effect) [77]. The intervention groups receive
attention from the technical support team during the 1-year use
of the tools provided, and all groups may receive attention
during the collection of data at the three time points. Finally,
the GPs will be aware of “their” patients’participation in a study
in which HbA1c is the primary outcome, and this may induce
them to provide better treatment. We must avoid the effects of
other possible interventions given by these professionals. The
possibility that improvements may be caused by intensified
provider consultation has been described in a recently conducted
review [28], and researchers should be aware of this problem.
Research on barriers to intervention has been requested within
diabetes self-management interventions [78] and health research
in primary care [79]. Barriers to participation and adoption of
TM from the perspective of people who decline to participate
or who withdrew early from the trial have been described [80].
We do not have permission from the ethical committee to ask
patients who drop out during the study for the reasons. In-depth
interviews at the end of the study will, however, give us
qualitative data about the patients’ views of the intervention’s
usability and acceptability. We are also using evaluation tools
including questionnaires measuring the same topics [68,69],
and we are using the heiQ to identify psychosocial barriers to
behavior change [62]. Another concern for some participants
is that it is a time-consuming intervention because of its
technology focus. Patients may choose not to participate in the
study because of the time factor, and this may be a limitation
to recruitment. It has been shown that recruitment to primary
care trials is normally problematic, such as in the United
Kingdom [69]. This may also be a problem in Norway, where
there is less research in primary care than in specialist care.
However, there is little research on how to improve recruitment
in primary care studies. It is important to cooperate with health
care personnel in the communities when developing an
intervention directed toward “their” patients, and where user
involvement is of great importance. Politicians and other
stakeholders in the communities should both order and
participate in research in this area [7]. This should help increase
knowledge and competence for developing new and innovative
services for health care users and providers.
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